Rob Kramer, Ph.D.
Rob Kramer is a proven oncology research leader with 23 years of experience working in the biopharmaceutical industry. Prior to becoming a consultant, Rob was Vice President and Global Head of Oncology Discovery for Johnson & Johnson. He also served as Vice President of Oncology and Immunology Drug Discovery for Bristol-Myers Squibb. Over the course of his career, Rob has managed teams that have advanced over 35 drug candidates from discovery to development, resulting in the approval of several cancer drugs. Rob has a Ph.D. from the University of Vermont.